We are live on ! Find out more
MXCT icon

MaxCyte
MXCT

114 hedge funds and large institutions have $269M invested in MaxCyte in 2024 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 50 increasing their positions, 38 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 38

1.14% more ownership

Funds ownership: 64.22% → 65.37% (+1.1%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

4% less capital invested

Capital invested by funds: $281M → $269M (-$12.3M)

7% less funds holding

Funds holding: 123 → 114 (-9)

43% less call options, than puts

Call options by funds: $8K | Put options by funds: $14K

47% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 17

Holders
114
Holders Change
-9
Holders Change %
-7.32%
% of All Funds
1.65%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
9
Increased
50
Reduced
38
Closed
17
Calls
$8K
Puts
$14K
Net Calls
-$6K
Net Calls Change
-$14K

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$4.82M
2
CCM
Cadian Capital Management
New York
+$4.57M
3
BlackRock
BlackRock
New York
+$3.93M
4
MA
Mudita Advisors
United Kingdom
+$3.06M
5
Marshall Wace
Marshall Wace
United Kingdom
+$2.15M

Top Sellers

1
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$8.71M
2
Millennium Management
Millennium Management
New York
-$4.27M
3
Allspring Global Investments
Allspring Global Investments
North Carolina
-$1.19M
4
GPGA
Grandeur Peak Global Advisors
Utah
-$1.01M
5
AIMCA
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
-$459K
Name Holding Trade Value Shares
Change 		Change in
Stake
Lazard Asset Management
26
Lazard Asset Management
New York
$1.62M -$236K -54,789 -12%
FAM
27
Fred Alger Management
New York
$1.54M -$23.2K -5,390 -1%
Goldman Sachs
28
Goldman Sachs
New York
$1.36M +$701K +162,994 +88%
AMH
29
Apollo Management Holdings
New York
$1.21M – – –
Charles Schwab
30
Charles Schwab
California
$1.17M +$241K +56,020 +23%
RG
31
Rathbones Group
United Kingdom
$1.07M -$86.6K -20,135 -7%
William Blair & Company
32
William Blair & Company
Illinois
$1.06M -$12K -2,795 -1%
N
33
Nuveen
North Carolina
$1.05M +$88.4K +20,549 +8%
BL
34
Bleichroeder LP
New York
$1.02M – – –
UBS AM
35
UBS AM
Illinois
$905K +$356K +82,801 +56%
Renaissance Technologies
36
Renaissance Technologies
New York
$827K +$208K +48,314 +30%
JP Morgan Chase
37
JP Morgan Chase
New York
$822K -$138K -32,000 -13%
RA
38
Royce & Associates
New York
$794K +$521K +121,224 +149%
AG
39
Algert Global
California
$794K -$28.3K -6,580 -3%
Swiss National Bank
40
Swiss National Bank
Switzerland
$723K +$46.9K +10,900 +6%
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$618K +$89.8K +20,864 +15%
Bank of America
42
Bank of America
North Carolina
$605K +$92.8K +21,583 +16%
Bank of Montreal
43
Bank of Montreal
Ontario, Canada
$601K – – –
American Century Companies
44
American Century Companies
Missouri
$565K +$59.8K +13,904 +11%
Squarepoint
45
Squarepoint
New York
$564K -$108K -25,153 -15%
SO
46
STRS Ohio
Ohio
$472K +$52.9K +12,300 +11%
Jane Street
47
Jane Street
New York
$461K +$265K +61,500 +110%
VA
48
Valmark Advisers
Ohio
$445K -$11K -2,562 -2%
Legal & General Group
49
Legal & General Group
United Kingdom
$380K +$51.9K +12,061 +14%
US Bancorp
50
US Bancorp
Minnesota
$377K +$1.5K +348 +0.4%
1
2
3 4 5

MXCT Hedge Fund Activity: Q2 2024 in Review

114 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in MaxCyte (MXCT) for Q2 2024, worth a combined $269M — down 4.4% from $281M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of MXCT and 9 opened new positions — a net loss of 8 holders — while 38 trimmed existing stakes and 50 added.

The largest buyer was Morgan Stanley, adding an estimated $4.82M. The largest seller was Massachusetts Financial Services, cutting an estimated $8.71M.

  • 114 institutional investors held MaxCyte (MXCT) as of Q2 2024, down from 123 in Q1 2024.
  • Funds reported $269M of MaxCyte stock for Q2 2024, down 4.4% quarter-over-quarter.
  • 9 funds opened new MaxCyte positions in Q2 2024 and 17 closed out, a net change of -8 holders.
  • The largest MaxCyte buyer in Q2 2024 was Morgan Stanley, an estimated $4.82M added.
  • The largest MaxCyte seller in Q2 2024 was Massachusetts Financial Services, an estimated $8.71M sold.

Based on aggregated 13F filings for Q2 2024.